Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis: A randomized, double-blind, placebo-controlled trial

Susan L. Greenspan, Ronald D. Emkey, Henry G. Bone, Stuart R. Weiss, Norman H. Bell, Robert W. Downs, Clark McKeever, Sam S. Miller, Michael Davidson, Michael A. Bolognese, Anthony L. Mulloy, Norman Heyden, Mei Wu, Amarjot Kaur, Antonio Lombardi

Research output: Contribution to journal › Article › peer-review

210 Scopus citations

Fingerprint

Dive into the research topics of 'Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis: A randomized, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences